Bavencio and BSC Extends Survival in Bladder Cancer, Regardless of Diabetes Status
Bavencio plus best supportive care improves survival outcomes in advanced urothelial carcinoma, regardless of diabetes status. Among patients with advanced urothelial carcinoma, first-line maintenance treatment with Bavencio (avelumab) plus best supportive care (BSC) prolonged overall survival (OS) and progression-free survival […]
Bavencio and BSC Extends Survival in Bladder Cancer, Regardless of Diabetes Status Read More »
